These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 2462387)
41. Effects of granulocyte colony-stimulating factor (G-CSF) on bleomycin-induced lung injury of varying severity. Adachi K; Suzuki M; Sugimoto T; Yorozu K; Takai H; Uetsuka K; Nakayama H; Doi K Toxicol Pathol; 2003; 31(6):665-73. PubMed ID: 14585735 [TBL] [Abstract][Full Text] [Related]
42. Imbalance in the pro-hepatocyte growth factor activation system in bleomycin-induced lung fibrosis in mice. Phin S; Marchand-Adam S; Fabre A; Marchal-Somme J; Bantsimba-Malanda C; Kataoka H; Soler P; Crestani B Am J Respir Cell Mol Biol; 2010 Mar; 42(3):286-93. PubMed ID: 19448157 [TBL] [Abstract][Full Text] [Related]
43. [Effect of CsA bleomycin-induced interstitial pulmonary disease in mice]. Ren Y; Yang H; Zhu P; Fan CM; Wang YH; Li J; Liu H Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Mar; 28(3):232-6. PubMed ID: 22394628 [TBL] [Abstract][Full Text] [Related]
44. Attenuation of bleomycin-induced pulmonary fibrosis by follistatin. Aoki F; Kurabayashi M; Hasegawa Y; Kojima I Am J Respir Crit Care Med; 2005 Sep; 172(6):713-20. PubMed ID: 15976370 [TBL] [Abstract][Full Text] [Related]
45. Synergistic effect of bolus exposure to zinc oxide nanoparticles on bleomycin-induced secretion of pro-fibrotic cytokines without lasting fibrotic changes in murine lungs. Wu W; Ichihara G; Hashimoto N; Hasegawa Y; Hayashi Y; Tada-Oikawa S; Suzuki Y; Chang J; Kato M; D'Alessandro-Gabazza CN; Gabazza EC; Ichihara S Int J Mol Sci; 2014 Dec; 16(1):660-76. PubMed ID: 25561223 [TBL] [Abstract][Full Text] [Related]
46. Effects of an interferon inducer bropirimine on bleomycin-induced lung fibrosis in hamsters. Zia S; Hyde DM; Giri SN Pharmacol Toxicol; 1992 Jul; 71(1):11-8. PubMed ID: 1381833 [TBL] [Abstract][Full Text] [Related]
47. Morphometric estimates of infiltrative cellular changes during the development of bleomycin-induced pulmonary fibrosis in hamsters. Chandler DB; Hyde DM; Giri SN Am J Pathol; 1983 Aug; 112(2):170-7. PubMed ID: 6192723 [TBL] [Abstract][Full Text] [Related]
48. [Relationship between bleomycin-induced pulmonary fibrosis and vascular endothelial cell injury]. Wei JG; Cui GB; Wang W; Wei LX; Liang GM; Song LJ; Xu JK Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2004 Oct; 22(5):354-7. PubMed ID: 15555311 [TBL] [Abstract][Full Text] [Related]
49. Time-dependent effect of inhaled cigarette smoke exposure in the bleomycin-induced lung injury rat model. Go RE; Lee SM; Shin YJ; Kim MS; Park CM; Ko EB; Kim S; Choi KC Environ Toxicol; 2022 May; 37(5):1231-1243. PubMed ID: 35112775 [TBL] [Abstract][Full Text] [Related]
50. Bleomycin-induced lung injury in the rabbit. Analysis and correlation of bronchoalveolar lavage, morphometrics, and fibroblast stimulating activity. Bigby TD; Allen D; Leslie CG; Henson PM; Cherniack RM Am Rev Respir Dis; 1985 Sep; 132(3):590-5. PubMed ID: 2412475 [TBL] [Abstract][Full Text] [Related]
51. A kampo medicine, Yin-Chiao-san, prevents bleomycin-induced pulmonary injury in rats. Yen FL; Wu TH; Liao CW; Lin CC Phytother Res; 2007 Mar; 21(3):251-8. PubMed ID: 17177325 [TBL] [Abstract][Full Text] [Related]
52. Toll like receptor 2 mediates bleomycin-induced acute lung injury, inflammation and fibrosis in mice. Liu HZ; Yang HZ; Mi S; Cui B; Hua F; Hu ZW Yao Xue Xue Bao; 2010 Aug; 45(8):976-86. PubMed ID: 21348427 [TBL] [Abstract][Full Text] [Related]
53. Oropharyngeal aspiration of bleomycin: An alternative experimental model of pulmonary fibrosis developed in Swiss mice. Bale S; Sunkoju M; Reddy SS; Swamy V; Godugu C Indian J Pharmacol; 2016; 48(6):643-648. PubMed ID: 28066100 [TBL] [Abstract][Full Text] [Related]
54. Hyaluronan (hyaluronic acid) in bronchoalveolar lavage fluid during the development of bleomycin-induced alveolitis in the rat. Nettelbladt O; Hällgren R Am Rev Respir Dis; 1989 Oct; 140(4):1028-32. PubMed ID: 2478053 [TBL] [Abstract][Full Text] [Related]
55. [Experimental studies on the pathogenesis and development of interstitial pneumonia and pulmonary fibrosis]. Yamakido M Nihon Kyobu Shikkan Gakkai Zasshi; 1989 Apr; 27(4):445-7. PubMed ID: 2477577 [TBL] [Abstract][Full Text] [Related]
56. Toxicological implication of prostaglandin transporter SLCO2A1 inhibition by cigarette smoke in exacerbation of lung inflammation. Nakanishi T; Sakiyama S; Takashima H; Honda R; Shumba MN; Nakamura Y; Kasahara K; Tamai I Toxicol Appl Pharmacol; 2020 Oct; 405():115201. PubMed ID: 32828905 [TBL] [Abstract][Full Text] [Related]
57. 3-week inhalation exposure to cigarette smoke and/or lipopolysaccharide in AKR/J mice. Lee KM; Renne RA; Harbo SJ; Clark ML; Johnson RE; Gideon KM Inhal Toxicol; 2007 Jan; 19(1):23-35. PubMed ID: 17127640 [TBL] [Abstract][Full Text] [Related]
58. Prolonged monocyte accumulation in the lung during bleomycin-induced pulmonary fibrosis. A noninvasive assessment of monocyte kinetics by scintigraphy. Doherty DE; Hirose N; Zagarella L; Cherniack RM Lab Invest; 1992 Feb; 66(2):231-42. PubMed ID: 1370968 [TBL] [Abstract][Full Text] [Related]
59. [Effects of curcumin on bleomycin-induced damages in pulmonary functions in rats]. Zhao CJ; Niu JZ; Wang JF; Zhou G; Tang BH Zhongguo Zhong Yao Za Zhi; 2008 Jun; 33(12):1434-8. PubMed ID: 18837350 [TBL] [Abstract][Full Text] [Related]
60. Early granulocyte-macrophage colony-stimulating factor expression by alveolar inflammatory cells during bleomycin-induced rat lung fibrosis. Andreutti D; Gabbiani G; Neuville P Lab Invest; 1998 Dec; 78(12):1493-502. PubMed ID: 9881949 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]